TFAP4 Promotes Hepatocellular Carcinoma Invasion and Metastasis via Activating the PI3K/AKT Signaling Pathway

PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K/Akt/GSK-3β/Snail signaling

(2018) Hai Jiang et al.   CANCER SCIENCE

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2018) Peter R. Galle et al.   JOURNAL OF HEPATOLOGY

The Transcription Factor AP4 Promotes Oncogenic Phenotypes and Cisplatin Resistance by RegulatingLAPTM4BExpression

(2018) Lu Wang et al.   MOLECULAR CANCER RESEARCH

Transcription factor AP-4 promotes tumorigenic capability and activates the Wnt/β-catenin pathway in hepatocellular carcinoma

(2018) Junwei Song et al.   Theranostics

The transcription factor Krüppel-like factor 5 promotes cell growth and metastasis via activating PI3K/AKT/Snail signaling in hepatocellular carcinoma

(2018) Tingting An et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

AP4 modulated by the PI3K/AKT pathway promotes prostate cancer proliferation and metastasis of prostate cancer via upregulating L-plastin

(2017) Changhao Chen et al.   Cell Death & Disease

Overexpression of transcription factor activating enhancer binding protein 4 (TFAP4) predicts poor prognosis for colorectal cancer patients

(2017) Jianchang Wei et al.   Experimental and Therapeutic Medicine

Expression profile and prognostic value of glypican-3 in post-operative South Korean hepatocellular carcinoma patients

(2016) Yejoo Jeon et al.   APMIS

Cyproheptadine exhibits antitumor activity in urothelial carcinoma cells by targeting GSK3β to suppress mTOR and β-catenin signaling pathways

(2016) Hsiao-Yen Hsieh et al.   CANCER LETTERS

International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007

(2016) Jessica L. Petrick et al.   INTERNATIONAL JOURNAL OF CANCER

14-3-3β Promotes Migration and Invasion of Human Hepatocellular Carcinoma Cells by Modulating Expression of MMP2 and MMP9 through PI3K/Akt/NF-κB Pathway

(2016) Yufu Tang et al.   PLoS One

NFκB- and AP-1-mediated DNA looping regulates matrix metalloproteinase-9 transcription in TNF-α-treated human leukemia U937 cells

(2015) Ying-Jung Chen et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Glabridin inhibits migration and invasion by transcriptional inhibition of matrix metalloproteinase 9 through modulation of NF-κB and AP-1 activity in human liver cancer cells

(2014) Ming-Ju Hsieh et al.   BRITISH JOURNAL OF PHARMACOLOGY

AP-4 predicts poor prognosis in non-small cell lung cancer

(2014) HAI GONG et al.   Molecular Medicine Reports

AP4 is a mediator of epithelial–mesenchymal transition and metastasis in colorectal cancer

(2013) Rene Jackstadt et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Continuous Improvement of Survival Outcomes of Resection of Hepatocellular Carcinoma

(2011) Sheung Tat Fan et al.   ANNALS OF SURGERY

The overexpression of AP-4 as a prognostic indicator for gastric carcinoma

(2011) Liu Xinghua et al.   MEDICAL ONCOLOGY

Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma

(2010) Yilei Mao et al.   GUT

Present and future possibilities for early diagnosis of hepatocellular carcinoma

(2010) Piotr Stefaniuk   WORLD JOURNAL OF GASTROENTEROLOGY

α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma

(2009) Jorge A. Marrero et al.   GASTROENTEROLOGY

Does the Expression of Cyclin E, pRb, and p21 Correlate with Prognosis in Gastric Adenocarcinoma?

(2008) Gregory Kouraklis et al.   DIGESTIVE DISEASES AND SCIENCES

AP4 encodes a c-MYC-inducible repressor of p21

(2008) P. Jung et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA